Benefit from adrenocorticotrophin in myasthenia gravis

Twenty-one of 29 patients suffering from myasthenia gravis derived benefit from a short intensive course of adrenocorticotrophin (ACTH). The mean duration of benefit was approximately six months. The best results were obtained in patients with a short history of myasthenia. Transient deterioration d...

Celý popis

Podrobná bibliografie

Vydáno v:	J Neurol Neurosurg Psychiatry
Hlavní autoři:	Liversedge, L. A., Yuill, G. M., Wilkinson, I. M. S., Hughes, J. A.
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMJ Publishing Group 1974
Témata:	Articles
On-line přístup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC494671/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/4365243/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/jnnp.37.4.412
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!